Research progress of donepezil for treating mild to moderate Alzheimer's disease

Abstract

Donepezil is the second generation of cholinesterase inhibitors (ChEIs), which has a good effect on mild to moderate Alzheimer's disease (AD). In recent years, there were a lot of studies on the mechanism of donepezil. This paper mainly introduces the diagnosis and treatment situation of AD in China, and the action mechanism of donepezil in the treatment of mild to moderate AD.

DOI: 10.3969/j.issn.1672-6731.2017.02.012